More Aggressive Breast Cancers Result of Gene Fusion

More Aggressive Breast Cancers Result of Gene Fusion
Gene Fusion breast cancersA collaboration between Dr. Xiaosong Wang and Dr. Rachel Schiff, both from the Lester and Sue Smith Breast Cancer Center at Baylor College of Medicine, discovered a genetic reason for more aggressive forms of luminal B breast cancer subtypes, which are estrogen-receptor positive (ER+). As detailed in their report published in Nature Communications, entitled, "Recurrent ​ESR1–​CCDC170 rearrangements in an aggressive subset of ​estrogen receptor-positive breast cancers," the gene fusion known as ESR1-CCDC170 is common in luminal, ER+ tumors. "While expressing the estrogen receptor, the luminal B breast cancers usually have higher tumor grade, larger tumor size, and poor prognosis, with most cases difficult to treat by endocrine therapy," said Dr. Wang in a news release from BCM. "We wanted to gain a deeper understanding about the genetic alterations underlying this particular form of breast cancer, because we do not know about what malfunctions potentially cause this form to be more aggressive." To do so, the collaborators, along with lead authors Dr. Jamunarani Veeraraghavan, Dr. Ying Tan, and Dr. Xi-Xi Cao, studied 200 tumor samples from the Lester and Sue Smith Breast Cen
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.